SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-08-000326
Filing Date
2008-11-20
Accepted
2008-11-20 06:30:29
Documents
2
Period of Report
2008-11-20
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SCICLONE PHARMACEUTICALS, INC. 8-K sciclonepharmaceuticals8k.htm 8-K 6838
2 SCICLONE PHARMACEUTICALS, INC. PRESS RELEASE sciclonepharmaceuti.htm EX-99 5352
  Complete submission text file 0001102624-08-000326.txt   13816
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 081202428
SIC: 2834 Pharmaceutical Preparations